MedPath

Gaviscon Infant

Brand Name: Gaviscon Infant

Generic Name: Sodium Alginate + Magnesium Alginate

Active
Registration Number

DR-XY46801

Dosage Form

Powder For Oral Suspension

Issuance Date

November 2, 2024

Expiry Date

January 21, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength225 mg / 87.5 mg
PackagingLDPE Laminate Sachet x 650mg (Box of 10's, 20's and 30's)

Classification

C
Classification
Over-The-Counter (OTC)
P
Pharmacologic
Antacid/ Anti-Reflux
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Sodium AlginateActive
Monograph: Alginic acid
Magnesium AlginateActive
Monograph: magnesium alginate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform